Shore, N. D., de Almeida Luz, M., De Giorgi, U., Gleave, M., Gotto, G. T., Pieczonka, C. M., . . . Freedland, S. J. (2026). Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer. New England Journal of Medicine, 394(6), 563. https://doi.org/10.1056/NEJMoa2510310
Chicago Style (17th ed.) CitationShore, Neal D., et al. "Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer." New England Journal of Medicine 394, no. 6 (2026): 563. https://doi.org/10.1056/NEJMoa2510310.
MLA (9th ed.) CitationShore, Neal D., et al. "Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer." New England Journal of Medicine, vol. 394, no. 6, 2026, p. 563, https://doi.org/10.1056/NEJMoa2510310.